mTORC2 contributes to the metabolic reprogramming in EGFR tyrosine-kinase inhibitor resistant cells in non-small cell lung cancer

por Chiang, Chun-Te, Demetriou, Alexandra N., Ung, Nolan, Choudhury, Niharika, Ghaffarian, Kimya, Ruderman, Daniel L., Mumenthaler, Shannon M.
Publicado 2018